|
TB-Related Articles
Return to TB-Related Articles
Table of Contents
Journal Articles Published by Division of TB
Elimination (DTBE) Authors
January - December 2006
Andre MD, Ijaz K, Tillinghast JD, Krebs VE, Diem LA, Metchock B,
Crisp T, and McElroy PD. Transmission network analysis to complement
routine tuberculosis contact investigations. Am J Public Health Nov.
2006; 96(11): 1-8.
Asghar RJ. Promoting regional health cooperation: the South Asian
Public Health Forum. PLoS Med 2006; 3(5): e108. Available online May
2006.
Burman W, Benator D, Vernon A, Khan A, Jones B, Silva C, Lahart
C, Weis S, King B, Mangura B, Weiner M, El-Sadr W, and Tuberculosis
Trials Consortium. Acquired rifamycin resistance with twice-weekly
treatment of HIV-related tuberculosis. American Journal of
Respiratory and Critical Care Med 2006 Feb 1; 173(3): 350-6.
Burman WJ, Goldberg S, Johnson JL, Muzanye G, Engle M, Mosher AW,
Choudhri S, Daley CL, Munsiff SS, Zhao Z, Vernon A, Chaisson RE, and
the Tuberculosis Trials Consortium. Moxifloxacin versus ethambutol
in the first 2 months of treatment for pulmonary tuberculosis. Am J Respir Crit Care Med 2006; 174: 331-338.
Caoili JC, Mayorovo A, Sikes D, Hickman L, Plikaytis BB, Shinnick
TM. Evaluation of the TB-Biochip oligonucleotide microarray system
for rapid detection of rifampin resistance in Mycobacterium
tuberculosis. Journal of Clinical Microbiology 2006 July; 44(7):
2378-2381.
Cattamanchi A, Hopewell P, Gonzalez LC, Osmond DH, Kawamura LM,
Daley CL, Jasmer RM. A 13-year molecular epidemiological analysis of
tuberculosis in San Francisco. International Journal of Tuberculosis
and Lung Disease March 2006; 10(3): 297-304(8).
Clark CM, Driver CR, Munsiff SS, Driscoll JR, Kreiswirth BN, Zhao
B, et al. Universal genotyping in tuberculosis control program, New
York City, 2001–2003. Emerg Infect Dis 2006 May; 12(5): 719-724.
Also available on Internet from
http://www.cdc.gov/ncidod/EID/vol12no05/05-0446.htm.
Dewan PK, Grinsdale J, Liska S, Wong E, Fallstad R, Kawamura LM.
Feasibility, acceptability, and cost of tuberculosis testing by
whole-blood interferon-gamma assay. BMC Infectious Diseases 2006 Mar
15; 6: 47 [online].
Dewan PK, Lal SS, Lonnroth K, Wares F, Uplekar M, Sahu S, Granich
R, and Chauhan LS. Improving tuberculosis control through
public-private collaboration in India: literature review. BMJ 2006
Mar 11; 332(7541): 574-8. Also available as e-pub 2006 Feb 8.
Holtz TH, Lancaster J, Laserson KF, Wells CD, Thorpe L, Weyer K.
Risk factors associated with default from multidrug-resistant
tuberculosis treatment, South Africa, 1999–2001. Int J Tuberc Lung
Dis June 2006; 10(6): 649-655.
Holtz TH, Sternberg M, Kammerer S, Laserson K, Riekstina V,
Zarovska E, Skripconoka V, Wells C, Leimane V. Time to sputum
culture conversion in multidrug-resistant tuberculosis: predictors
and relationship to treatment outcome. Annals of Internal Medicine
2006; 144(9): 650-660.
Ijaz K, Jereb J, Lambert L, Bower W, Spradling P, McElroy P,
Iademarco M, Navin T, and Castro K. Severe or fatal liver injury in
50 patients in the United States taking rifampin and pyrazinamide
for latent tuberculosis infection. Clinical Infectious Diseases
2006; 42: 346-355.
Johansen SK, Maus CE, Plikaytis BB, Douthwaite S. Capreomycin
binds across the ribosomal subunit interface using tlyA-encoded
2′-O-methylations in 16S and 23S rRNAs. Molecular Cell 2006 July 21;
23: 173-182.
Khan A, Sterling TR, Reves R, Vernon A, Horsburgh CR, and the
Tuberculosis Trials Consortium. Lack of weight gain and relapse risk
in a large tuberculosis treatment trial. Am J Respir Crit Care Med
2006; 174: 344-348.
Lee LM, Lobato MN, Buskin SE, Morse A, Costa S. Low adherence to
guidelines for preventing TB among persons with newly diagnosed HIV
infection, United States. International Journal of Tuberculosis and
Lung Disease 2006; 10(2): 209-214.
Lobato MN, Wang YC, Becerra JE, Simone PM, and Castro KG.
Improved program activities are associated with decreasing
tuberculosis incidence in the United States. Public Health Reports
2006 Mar-Apr; 121(2): 108-15.
Lofy KH, McElroy PD, Lake L, Cowan LS, Diem LA, Goldberg SV,
Cangelosi GA, Tribble SP, Cave MD, Narita M. Outbreak of
tuberculosis in a homeless population involving multiple sites of
transmission. Int J Tuberc Lung Dis June 2006; 10(6): 683-689.
Macaraig M, Agerton T, Driver CR, Munsiff SS, Abdelwahab J, Park
J, Kreiswirth B, Driscoll J, and Zhao B. Strain-specific differences
in two large Mycobacterium tuberculosis genotype clusters in
isolates collected from homeless patients in New York City from 2001
to 2004. Journal of Clinical Microbiology 2006 Aug; 44(8): 2890-6.
Maloney SA, Fielding KL, Laserson KF, et al. Assessing the
performance of overseas tuberculosis screening programs: a study
among US-bound immigrants in Vietnam. Arch Intern Med 2006; (2)166:
234-240.
Manangan LP, Moore M, Macaraig M, MacNeil J, Shevick G, Northrup
J, Pratt R, Adams LV, Boutotte J, Sharnprapai S, Qualls N. Health
department costs of managing persons with suspected and noncounted
tuberculosis in New York City, three Texas counties, and
Massachusetts. J Public Health Management and Practice 2006; 12(3):
248-253.
Miller TL, Hilsenrath P, Lykens K, McNabb SJN, Moonan PK, and
Weis SE. Using cost and health impacts to prioritize the targeted
testing of tuberculosis in the United States. Annals of Epidemiology
2006; 16: 305-312.
Moonan PK, Oppong J, Sahbazian B, Singh KP, Sandhu R, Drewyer G,
Lafon T, Marruffo M, Quitugua TN, Wallace C, and Weis SE. What is
the outcome of targeted tuberculosis screening based on universal
genotyping and location? American Journal of Respiratory and
Critical Care Medicine 2006 Sep 1; 174(5): 599-604. Also available
as e-pub 2006 May 25.
Mugisha B, Bock N, Mermin J, Odeke RM, Miller B, Adatu-Engwau F,
Granich R, Bunnell R. Tuberculosis case finding and preventive
therapy in an HIV voluntary counseling and testing center in Uganda.
Int J Tuberc Lung Dis July 2006; 10(7): 761-767.
Munsiff SS, Ahuja SD, King L, Udeagu C-C, Dorsinville M, Frieden
TR, Fujiwara PI. Ensuring accountability: the contribution of the
cohort review method to tuberculosis control in New York City. Int J
Tuberc Lung Dis 2006; 10(10): 1133-1139.
Munsiff SS, Ahuja SD, Li J, Driver CR. Public-private
collaboration for multidrug-resistant tuberculosis control in New
York City. Int J Tuberc Lung Dis June 2006; 10(6): 639-648.
Munsiff SS, Li J, Cook SV, Piatek A, Laraque F, Ebrahimzadeh A,
and Fujiwara PI. Trends in drug-resistant Mycobacterium tuberculosis
in New York City, 1991-2003. Clinical Infectious Diseases 2006 Jun
15; 42(12): 1702-10. Also available as e-pub 2006 May 12.
Nathanson E, Lambregts-van Weezenbeek C, Rich ML, Gupta R, Bayona
J, Blöndal K, et al.
Multidrug-resistant tuberculosis management in
resource-limited settings. Emerg Infect Dis 2006 Sept;
12(9): 1389-1397.
Oeltmann JE, Oren E, Haddad MB, Lake LK, Harrington TA, Ijaz K,
Narita M.
Tuberculosis outbreak in marijuana users—Seattle,
Washington, 2004. Emerg Infect Dis 2006 July;
12(7): 1156-1159.
Posey JE, Shinnick TM, and Quinn FD. Characterization of the
twin-arginine translocase secretion system of Mycobacterium
smegmatis. Journal of Bacteriology 2006 Feb; 188(4): 1332–1340.
Reid A, Scano F, Getahun H, Williams B, Dye C, Nunn P, De Cock
KM, Hankins C, Miller B, Castro KG, and Raviglione MC. Towards
universal access to HIV prevention, treatment, care, and support:
the role of tuberculosis/HIV collaboration. The Lancet Infectious
Diseases 2006 Aug; 6(8): 483-95.
Roberts C, Lobato M, Bazerman L, Kling R, Reichard A, Hammett T.
Tuberculosis prevention and control in large jails: a challenge to
tuberculosis education. American Journal of Preventive Medicine
2006: 30(2); 125-130.
Sackoff JE, Pfeiffer MR, Driver CR, Streett LS, Munsiff SS, and
DeHovitz JA. Tuberculosis prevention for non-US-born pregnant women.
American Journal of Obstetrics and Gynecology 2006 Feb; 194(2):
451-6.
Saukkonen JJ, Cohn DL, Jasmer RM, Schenker S, Jereb JA, Nolan CM,
Peloquin CA, Gordin FM, Nunes D, Strader DB, Bernardo J,
Venkataramanan R, and Sterling TR. An Official ATS Statement:
Hepatotoxicity of Antituberculosis Therapy. American Journal of
Respiratory and Critical Care Medicine 2006 Oct 15; 174 (8):935-52.
Shah NS, Harrington T, Huber M, Wellnitz C, Fridrych S, Laserson
K, Gonzalez IM, and Ijaz K. Increased reported cases of tuberculosis
among children younger than 5 years of age, Maricopa County,
Arizona, 2002-2003. The Pediatric Infectious Disease Journal 2006
Feb; 25 (2): 151-5.
Sterling TR, Bethel J, Goldberg S, Weinfurter P, Yun L, Horsburgh
CR, and the Tuberculosis Epidemiologic Studies Consortium. The scope
and impact of treatment of latent tuberculosis infection in the
United States. Am J Respir Crit Care Med 2006; 173:927-931.
Sterling TR, Zhao Z, Khan A, Chaisson RE, Schluger N, Mangura B,
Weiner M, Vernon A for the Tuberculosis Trials Consortium. Mortality
in a large tuberculosis treatment trial: modifiable and
non-modifiable risk factors. Int J Tuberc Lung Dis May 2006;
10(5):542-549.
Yagui M, Perales MT, Asencios L, Vergara L, Suarez C, Yale G,
Salazar C, Saavedra M, Shin S, Ferrousier O, Cegielski P. Timely
diagnosis of MDR-TB under program conditions: is rapid drug
susceptibility testing sufficient? Int J Tuberc Lung Dis August
2006; 10(8):838-843.
Last Reviewed: 05/18/2008 Content Source: Division of Tuberculosis Elimination
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
|